Thomas A. McCourt
2016
In 2016, Thomas A. McCourt earned a total compensation of $1.5M as President at Ironwood Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $288,000 |
|---|---|
| Option Awards | $813,225 |
| Salary | $435,000 |
| Other | $8,040 |
| Total | $1,544,265 |
McCourt received $813.2K in option awards, accounting for 53% of the total pay in 2016.
McCourt also received $288K in non-equity incentive plan, $435K in salary and $8K in other compensation.
Rankings
In 2016, Thomas A. McCourt's compensation ranked 6,104th out of 14,075 executives tracked by ExecPay. In other words, McCourt earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,104 out of 14,075 | 57th |
Division Manufacturing | 2,229 out of 5,489 | 59th |
Major group Chemicals And Allied Products | 732 out of 1,895 | 61st |
Industry group Drugs | 553 out of 1,538 | 64th |
Industry Pharmaceutical Preparations | 433 out of 1,176 | 63rd |
Source: SEC filing on April 26, 2019.
McCourt's colleagues
We found two more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2016.
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019